Summary
The company behind Mounjaro are aiming to replace injections with a tablet called Orforglipron next year, potentially (re)revolutionising how we tackle obesity. GQ speaks to a range of experts on what this could mean good and bad
Source: British Gq
Exclusive AI-Powered News Insights (For Members only)
Disclaimer:This content is AI-generated from various trusted sources and is intended for informational purposes only. While we strive for accuracy, we encourage you to verify details independently. Use the contact button to share feedback on any inaccuracies—your input helps us improve!
